March 31, 2016 – Santa Barbara, CA: The Judicial Panel on Multidistrict Litigation will hold a hearing to consider a request to establish coordinated national litigation against the manufacturers of Viagra. The Judicial Panel is a group of federal judges who meet every other month to consider requests for the […]
Author: Brenda Fulmer
The hip shoe and sunglasses company TOMS has set the bar for giving back to the community through its One for One movement. The Southern California-based business helps someone in need for every product it sells and, since its founding in 2006, has distributed 10 million pairs of shoes to […]
Earlier this week, a Missouri appeals court issued an opinion that will hopefully have a significant impact on ongoing litigation against the manufacturers of metoclopramide, the generic version of Reglan. In this latest case, the appeals court found that plaintiffs Franzman and Niceley, both of whom suffered tardive dyskinesia after […]
A lot can be misconstrued in the silent world of the Internet. While online technology has changed the communications paradigm, it also has resulted in bad information, embarrassing typos, factual errors and malfeasance. Fake Web sites, botched emails, rambling blogs and photo abuse appear in cyberspace every day. Most of […]
The Food and Drug Administration is considering some very important changes to its internal rules that would help to eliminate a loophole in accountability for defective drugs. Under current law, only the brand name manufacturer is permitted to change the warning label for a particular drug. After a drug is […]
The first hearing for the newly-created Pradaxa MDL has been scheduled for October 3, 2012, at 1:30 PM at the United States Courthouse in East St. Louis, Illinois. On August 8, 2012, the Judicial Panel on Multi-District Litigation (JPML) granted the plaintiffs’ request for establishment of an MDL and assigned […]
There are growing safety concerns over the anti-arrhythmia drug Multaq, (dronedarone), which is manufactured and marketed by Sanofi-Aventis and has generated a great deal of controversy and concern in just a few short years. Multaq was first approved by the Food & Drug Administration (“FDA”) in 2009 for use as […]
As depicted in the following video, over the years, cardiologists have relied upon invasive catheterization to diagnose cardiac-related blood flow problems and muscle wall damage. However, placing a catheter into blood vessels and guiding it into the heart is technique-sensitive, and is far more invasive and less diagnostic than the […]
Many physical, social, and chemical changes happen to a woman both before and after her pregnancy. These changes can lead to women suffering from a number of symptoms including depression. In fact, it has been said that one out of every five women has symptoms of depression during their pregnancy. […]
Over the past decade, the Food & Drug Administration has made great efforts to provide improved safety information to patients and consumers. The FDA web site includes a number of helpful materials: warning labels, podcasts white papers prepared for scientific panels that summarize complex medical and scientific data Power Point […]
